Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
S&P Global Mobility Recognizes the 29th Annual Automotive Loyalty Awards Winners; General Motors, Tesla and Lincoln Corsair Lead the Industry in Retention in 2024
-
Eikon Therapeutics Secures $350.7 Million Series D to Advance Clinical-Stage Programs and Future Pipeline
-
Bentley Systems Announces Fourth Quarter and Full Year 2024 Results and 2025 Financial Outlook
-
NATCOM: Revolutionizing Connectivity and Financial Inclusion in Haiti with International Top-Up and Natcash Remittance Services
-
Bybit and Solana Summit's Livestreams Cites Community Power and SVM Use Cases as Ultimate Growth Catalysts in 2025
-
Zevia Announces Fourth Quarter and Full Year 2024 Results
-
Adcendo ApS Announces U.S. FDA Clearance of IND Application for Phase I Tiffany-01 Trial of ADCE-T02
-
Opthea Completes Drug Product PPQ Campaign
-
UL Solutions to Attend the Raymond James 46th Annual Institutional Investors Conference
-
Innoviz Reports Fourth Quarter and Full Year 2024 Results
-
CitiusTech Launches CitiusTech HealthSPARX, A Real-World Data Platform for Life Sciences Organizations
-
Cognition Therapeutics Successfully Passes Pre-defined Futility Analysis of Phase 2 Study of Oral Zervimesine (CT1812) in Geographic Atrophy
-
Harris Williams Announces Senior-Level Promotions
-
Camizestrant demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival in 1st-line advanced HR-positive breast cancer with an emergent ESR1 tumor
-
Cyngn Announces Date for 2024 Fourth Quarter and Year-End Financial Results
-
Rithm Capital Corp. Announces a Redemption of $50 million of 7.50% Series A Fixed‑to‑Floating Rate Cumulative Redeemable Preferred Stock
-
Kairos Pharma Presents Preclinical Data on its Investigational Compounds KROS 101 and KROS 401 Further Supporting Both Compounds’ Potential as Therapeutics for Melanoma and Glioblastoma
-
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2025
-
Horizon Quantum Computing Pte. Ltd. and dMY Squared Technology Group, Inc. Sign Non-Binding Letter of Intent for a Business Combination
-
Dianthus Therapeutics to Participate in Two Upcoming Investor Conferences
-
Rockwell Automation to Present at the 2025 J.P. Morgan Industrials Conference
-
CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
-
Talisker Receives Positive Ore Sorting Results for the Bralorne Gold Project
-
Tilray Brands Announces 420 Concert with Multi-Platinum Artist Don Toliver
-
Lantheus Reports Fourth Quarter and Full Year 2024 Financial Performance
-
Infinity Natural Resources, Inc. to Participate in Raymond James 46th Annual Institutional Investors Conference
-
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update
-
Argobio and the Institut Pasteur Launch Enodia Therapeutics: A Biotech Company With a New Approach for Targeted Protein Degradation
-
The Vita Coco Company Reports Strong Fourth Quarter and Full Year 2024 Financial Results
-
Boundless Bio to Participate in the Leerink Global Healthcare Conference
-
Axsome Therapeutics to Participate in Upcoming Investor Conferences
-
Aquestive Therapeutics to Participate in Two Upcoming Conferences in March
-
Photronics Reports First Quarter Fiscal 2025 Results
-
Winnebago Industries to Present at the 46th Annual Raymond James Institutional Investors Conference
-
Village Farms International to Report Q4 and Full Year 2024 Results on March 13, 2025
-
REMINDER: Stella-Jones Will Hold a Conference Call to Discuss Its Fourth Quarter Results
-
Dycom Industries, Inc. Reports Fiscal 2025 Fourth Quarter and Annual Results and Provides Outlook
-
Kamada to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 5, 2025
-
Perspective Therapeutics to Present at Upcoming March Investor Conferences
-
WEBTOON Entertainment Inc. to Participate in Upcoming Investor Conferences
-
Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements
-
Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2024
-
Passage Bio to Participate in Upcoming Investor Conferences
-
Moody’s affirmed Aktia’s ratings and upgraded outlook from negative to stable
-
OXB to present at the Leerink Partners Global Healthcare Conference
-
MoonLake Immunotherapeutics Reports Full Year 2024 Financial Results and Provides a Business Update
-
Immunocore reports fourth quarter and full year 2024 financial results and provides a business update
-
Canada Goose Announces Participation in 46th Raymond James Institutional Investor Conference
-
Benitec Biopharma to Participate in Upcoming Conferences in March
-
Audiologists Stress Important Message to Video Gamers This World Hearing Day (March 3): Protect Your Hearing!
